In addition, elevated SNHG14 expression was related to tumor size (> 3.5 cm) [OR = 1.60; 95% CI: (1.20-2.14); <i>p</i> = 0.001], TNM staging [OR = 0.54; 95% CI: (0.40-0.71); <i>p</i> < 0.001], lymph node metastasis [OR = 1.86; 95% CI: (1.35-2.55); <i>p</i> < 0.001], differentiation grade [OR = 1.95; 95% CI: (1.36-2.80); <i>p</i> < 0.001], and distant metastasis [OR = 2.44; 95% CI: (1.30-4.58); <i>p</i> = 0.005]. This evidence concerns the gene SNHG14 and metastatic malignant neoplasm in the lymph nodes.